Table of Content

1 IPV Vaccine Market Overview
1.1 Product Overview and Scope of IPV Vaccine
1.2 IPV Vaccine Segment by Type
1.2.1 Global IPV Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Mahoney
1.2.3 MEF1
1.2.4 Saukett
1.3 IPV Vaccine Segment by Application
1.3.1 Global IPV Vaccine Market Value by Application: (2024-2034)
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global IPV Vaccine Market Size Estimates and Forecasts
1.4.1 Global IPV Vaccine Revenue 2018-2034
1.4.2 Global IPV Vaccine Sales 2018-2034
1.4.3 Global IPV Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 IPV Vaccine Market Competition by Manufacturers
2.1 Global IPV Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global IPV Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global IPV Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global IPV Vaccine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of IPV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IPV Vaccine, Product Type & Application
2.7 IPV Vaccine Market Competitive Situation and Trends
2.7.1 IPV Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IPV Vaccine Players Market Share by Revenue
2.7.3 Global IPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IPV Vaccine Retrospective Market Scenario by Region
3.1 Global IPV Vaccine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global IPV Vaccine Global IPV Vaccine Sales by Region: 2018-2034
3.2.1 Global IPV Vaccine Sales by Region: 2018-2023
3.2.2 Global IPV Vaccine Sales by Region: 2024-2034
3.3 Global IPV Vaccine Global IPV Vaccine Revenue by Region: 2018-2034
3.3.1 Global IPV Vaccine Revenue by Region: 2018-2023
3.3.2 Global IPV Vaccine Revenue by Region: 2024-2034
3.4 North America IPV Vaccine Market Facts & Figures by Country
3.4.1 North America IPV Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America IPV Vaccine Sales by Country (2018-2034)
3.4.3 North America IPV Vaccine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe IPV Vaccine Market Facts & Figures by Country
3.5.1 Europe IPV Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe IPV Vaccine Sales by Country (2018-2034)
3.5.3 Europe IPV Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IPV Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific IPV Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific IPV Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific IPV Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IPV Vaccine Market Facts & Figures by Country
3.7.1 Latin America IPV Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America IPV Vaccine Sales by Country (2018-2034)
3.7.3 Latin America IPV Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IPV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa IPV Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa IPV Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa IPV Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IPV Vaccine Sales by Type (2018-2034)
4.1.1 Global IPV Vaccine Sales by Type (2018-2023)
4.1.2 Global IPV Vaccine Sales by Type (2024-2034)
4.1.3 Global IPV Vaccine Sales Market Share by Type (2018-2034)
4.2 Global IPV Vaccine Revenue by Type (2018-2034)
4.2.1 Global IPV Vaccine Revenue by Type (2018-2023)
4.2.2 Global IPV Vaccine Revenue by Type (2024-2034)
4.2.3 Global IPV Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global IPV Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global IPV Vaccine Sales by Application (2018-2034)
5.1.1 Global IPV Vaccine Sales by Application (2018-2023)
5.1.2 Global IPV Vaccine Sales by Application (2024-2034)
5.1.3 Global IPV Vaccine Sales Market Share by Application (2018-2034)
5.2 Global IPV Vaccine Revenue by Application (2018-2034)
5.2.1 Global IPV Vaccine Revenue by Application (2018-2023)
5.2.2 Global IPV Vaccine Revenue by Application (2024-2034)
5.2.3 Global IPV Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global IPV Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 GlaxoSmithKline Plc
6.1.1 GlaxoSmithKline Plc Corporation Information
6.1.2 GlaxoSmithKline Plc Description and Business Overview
6.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Plc IPV Vaccine Product Portfolio
6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
6.2 Sanofi S.A
6.2.1 Sanofi S.A Corporation Information
6.2.2 Sanofi S.A Description and Business Overview
6.2.3 Sanofi S.A IPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi S.A IPV Vaccine Product Portfolio
6.2.5 Sanofi S.A Recent Developments/Updates
6.3 Serum Institute of India Pvt. Ltd.
6.3.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.3.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Product Portfolio
6.3.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.4 PT Bio Farma
6.4.1 PT Bio Farma Corporation Information
6.4.2 PT Bio Farma Description and Business Overview
6.4.3 PT Bio Farma IPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PT Bio Farma IPV Vaccine Product Portfolio
6.4.5 PT Bio Farma Recent Developments/Updates
6.5 AJ Vaccines
6.5.1 AJ Vaccines Corporation Information
6.5.2 AJ Vaccines Description and Business Overview
6.5.3 AJ Vaccines IPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AJ Vaccines IPV Vaccine Product Portfolio
6.5.5 AJ Vaccines Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IPV Vaccine Industry Chain Analysis
7.2 IPV Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IPV Vaccine Production Mode & Process
7.4 IPV Vaccine Sales and Marketing
7.4.1 IPV Vaccine Sales Channels
7.4.2 IPV Vaccine Distributors
7.5 IPV Vaccine Customers
8 IPV Vaccine Market Dynamics
8.1 IPV Vaccine Industry Trends
8.2 IPV Vaccine Market Drivers
8.3 IPV Vaccine Market Challenges
8.4 IPV Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global IPV Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global IPV Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global IPV Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global IPV Vaccine Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global IPV Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global IPV Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global IPV Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market IPV Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of IPV Vaccine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of IPV Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of IPV Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of IPV Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IPV Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IPV Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IPV Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global IPV Vaccine Sales by Region (2018-2023) & (Units)
Table 18. Global IPV Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global IPV Vaccine Sales by Region (2024-2034) & (Units)
Table 20. Global IPV Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global IPV Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global IPV Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global IPV Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global IPV Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America IPV Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America IPV Vaccine Sales by Country (2018-2023) & (Units)
Table 27. North America IPV Vaccine Sales by Country (2024-2034) & (Units)
Table 28. North America IPV Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America IPV Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe IPV Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe IPV Vaccine Sales by Country (2018-2023) & (Units)
Table 32. Europe IPV Vaccine Sales by Country (2024-2034) & (Units)
Table 33. Europe IPV Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe IPV Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific IPV Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific IPV Vaccine Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific IPV Vaccine Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific IPV Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific IPV Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America IPV Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America IPV Vaccine Sales by Country (2018-2023) & (Units)
Table 42. Latin America IPV Vaccine Sales by Country (2024-2034) & (Units)
Table 43. Latin America IPV Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America IPV Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa IPV Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa IPV Vaccine Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa IPV Vaccine Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa IPV Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa IPV Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global IPV Vaccine Sales (Units) by Type (2018-2023)
Table 51. Global IPV Vaccine Sales (Units) by Type (2024-2034)
Table 52. Global IPV Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global IPV Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global IPV Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global IPV Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global IPV Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global IPV Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global IPV Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global IPV Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global IPV Vaccine Sales (Units) by Application (2018-2023)
Table 61. Global IPV Vaccine Sales (Units) by Application (2024-2034)
Table 62. Global IPV Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global IPV Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global IPV Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global IPV Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global IPV Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global IPV Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global IPV Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global IPV Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. GlaxoSmithKline Plc Corporation Information
Table 71. GlaxoSmithKline Plc Description and Business Overview
Table 72. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GlaxoSmithKline Plc IPV Vaccine Product
Table 74. GlaxoSmithKline Plc Recent Developments/Updates
Table 75. Sanofi S.A Corporation Information
Table 76. Sanofi S.A Description and Business Overview
Table 77. Sanofi S.A IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sanofi S.A IPV Vaccine Product
Table 79. Sanofi S.A Recent Developments/Updates
Table 80. Serum Institute of India Pvt. Ltd. Corporation Information
Table 81. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 82. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Serum Institute of India Pvt. Ltd. IPV Vaccine Product
Table 84. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 85. PT Bio Farma Corporation Information
Table 86. PT Bio Farma Description and Business Overview
Table 87. PT Bio Farma IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. PT Bio Farma IPV Vaccine Product
Table 89. PT Bio Farma Recent Developments/Updates
Table 90. AJ Vaccines Corporation Information
Table 91. AJ Vaccines Description and Business Overview
Table 92. AJ Vaccines IPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. AJ Vaccines IPV Vaccine Product
Table 94. AJ Vaccines Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. IPV Vaccine Distributors List
Table 98. IPV Vaccine Customers List
Table 99. IPV Vaccine Market Trends
Table 100. IPV Vaccine Market Drivers
Table 101. IPV Vaccine Market Challenges
Table 102. IPV Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of IPV Vaccine
Figure 2. Global IPV Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global IPV Vaccine Market Share by Type in 2024 & 2034
Figure 4. Mahoney Product Picture
Figure 5. MEF1 Product Picture
Figure 6. Saukett Product Picture
Figure 7. Global IPV Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global IPV Vaccine Market Share by Application in 2024 & 2034
Figure 9. Private Distribution Channel
Figure 10. Public Distribution Channel
Figure 11. Global IPV Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global IPV Vaccine Market Size (2018-2034) & (US$ Million)
Figure 13. Global IPV Vaccine Sales (2018-2034) & (Units)
Figure 14. Global IPV Vaccine Average Price (US$/Unit) & (2018-2034)
Figure 15. IPV Vaccine Report Years Considered
Figure 16. IPV Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global IPV Vaccine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest IPV Vaccine Players: Market Share by Revenue in 2024
Figure 19. IPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global IPV Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America IPV Vaccine Sales Market Share by Country (2018-2034)
Figure 22. North America IPV Vaccine Revenue Market Share by Country (2018-2034)
Figure 23. United States IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe IPV Vaccine Sales Market Share by Country (2018-2034)
Figure 26. Europe IPV Vaccine Revenue Market Share by Country (2018-2034)
Figure 27. Germany IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific IPV Vaccine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific IPV Vaccine Revenue Market Share by Region (2018-2034)
Figure 34. China IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America IPV Vaccine Sales Market Share by Country (2018-2034)
Figure 44. Latin America IPV Vaccine Revenue Market Share by Country (2018-2034)
Figure 45. Mexico IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa IPV Vaccine Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa IPV Vaccine Revenue Market Share by Country (2018-2034)
Figure 50. Turkey IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE IPV Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of IPV Vaccine by Type (2018-2034)
Figure 54. Global Revenue Market Share of IPV Vaccine by Type (2018-2034)
Figure 55. Global IPV Vaccine Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of IPV Vaccine by Application (2018-2034)
Figure 57. Global Revenue Market Share of IPV Vaccine by Application (2018-2034)
Figure 58. Global IPV Vaccine Price (US$/Unit) by Application (2018-2034)
Figure 59. IPV Vaccine Value Chain
Figure 60. IPV Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed